CPIM
TRIB

Columbia Partners Investment Management’s Trinity Biotech TRIB Stock Holding History

Columbia Partners Investment Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-536
Closed -$1.47M – 358
2014
Q3 		$1.47M Buy
+536
New +$1.74M 0.07% 215

Other funds holding TRIB

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Columbia Partners Investment Management's TRIB Position: Q4 2014 in Review

Columbia Partners Investment Management sold out of Trinity Biotech (TRIB) in Q4 2014, closing a stake of 536 shares — an estimated $1.47M sold.

Columbia Partners Investment Management first reported a position in TRIB in Q3 2014 and held it in 1 quarter. The position peaked at $1.47M in Q3 2014. 92 funds tracked by Wall St. Rank hold TRIB as of Q4 2014.

  • Columbia Partners Investment Management reported no remaining Trinity Biotech position as of Q4 2014 after selling out during the quarter.
  • Columbia Partners Investment Management sold 536 Trinity Biotech shares in Q4 2014, an estimated $1.47M.
  • Columbia Partners Investment Management first reported a position in Trinity Biotech in Q3 2014 and held it in 1 quarter.
  • Columbia Partners Investment Management's Trinity Biotech position peaked at $1.47M in Q3 2014.
  • 92 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2014.

Based on Columbia Partners Investment Management's 13F filing for Q4 2014, filed 11 Feb 2015.